Hans-Peter Gerber
Chief Tech/Sci/R&D Officer bij SUTRO BIOPHARMA, INC.
Actieve functies van Hans-Peter Gerber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 18-09-2023 | - |
| T-CURX GmbH | Chairman | - | - |
Loopbaan van Hans-Peter Gerber
Eerdere bekende functies van Hans-Peter Gerber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Director/Board Member | 01-01-2017 | 01-01-2021 |
| Independent Dir/Board Member | 01-01-2017 | 01-01-2021 | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Director/Board Member | 01-01-2016 | 01-01-2018 |
| President | 01-01-2016 | 01-01-2018 |
Opleiding van Hans-Peter Gerber
| University of Zurich | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Zwitserland | 3 |
| Duitsland | 2 |
Operationeel
| Director/Board Member | 2 |
| President | 1 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |
| T-CURX GmbH |
- Beurs
- Insiders
- Hans-Peter Gerber
- Ervaring
